# Abbott Laboratories (ABT) — Q3-2023 Earnings Results

**Report date:** 2023-10-18 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2023

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 3.71%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +3.45% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported an earnings per share of $1.14, exceeding expectations slightly. The stock reacted positively, rising 3.71%, likely reflecting investor confidence in the company's performance despite the absence of revenue data and guidance. The lack of additional commentary from management leaves some uncertainty about future directions.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2023_